Wolf-dieter D. Ludwig

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Comparison of Uptake and Prices of Biosimilars in the US, Germany, and Switzerland.

Comparison of Uptake and Prices of Biosimilars in the US, Germany, and Switzerland.

Journal: JAMA network open

Published: December 02, 2022

Overtreatment at the End of Life in Oncology

Overtreatment at the End of Life in Oncology

Journal: Therapeutische Umschau. Revue therapeutique

Published: February 01, 2022

Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis.

Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis.

Journal: The Lancet. Oncology

Published: November 14, 2021

Educating physicians on strong opioids by descriptive versus simulated-experience formats: a randomized controlled trial.

Educating physicians on strong opioids by descriptive versus simulated-experience formats: a randomized controlled trial.

Journal: BMC medical education

Published: July 20, 2021

The role of simulated-experience and descriptive formats on perceiving risks of strong opioids: A randomized controlled trial with chronic noncancer pain patients.

The role of simulated-experience and descriptive formats on perceiving risks of strong opioids: A randomized controlled trial with chronic noncancer pain patients.

Journal: Patient education and counseling

Published: February 05, 2021

PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.

PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.

Journal: The Lancet. Haematology

Published: December 28, 2020

Experiencing the risk of overutilising opioids among patients with chronic non-cancer pain in ambulatory care (ERONA): the protocol of an exploratory, randomised controlled trial.

Experiencing the risk of overutilising opioids among patients with chronic non-cancer pain in ambulatory care (ERONA): the protocol of an exploratory, randomised controlled trial.

Journal: BMJ open

Published: September 08, 2020

Orphan drugs from the perspective of the Drug Commission of the German Medical Association : Opportunities and challenges

Orphan drugs from the perspective of the Drug Commission of the German Medical Association : Opportunities and challenges

Journal: Der Internist

Published: March 13, 2019

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study.

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study.

Journal: Leukemia

Published: May 16, 2018

Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trial.

Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trial.

Journal: British journal of haematology

Published: March 28, 2018

IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 03, 2018

Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).

Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 18, 2017

Showing 1-12 of 42

Last Updated: 09/26/2026